在ABGA相关脑炎中可逆性痴呆和失眠
Laura Mumoli1, Giuseppe Magro2, Emilio Le Piane1
1Azienda Ospedaliero Universitaria R. Dulbecco, Pugliese Ciaccio Hospital, Neurology Department, Catanzaro, Italy.
Sleep medicine
|April 6, 2024
概括
抗基底抗体 (ABGA) 可以导致可逆的大脑病变和神经精神症状在成年人,包括失眠和焦虑. 早期诊断和IV-免疫球蛋白治疗导致显著的临床改善.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 神经精神病学是一种神经精神病学.
背景情况:
- 抗基底抗体 (ABGAs) 历来与脑膜炎 (EL) 有关,主要影响神经精神疾病和超金字塔性疾病的儿童.
- 成人ABGA病例很少见,经常呈现异常运动障碍,并且通常与可逆的基底腺病变或自身免疫性脑炎无关.
- 埃尔的免疫病原性,特别是其高动力形式,仍然是研究领域.
研究的目的:
- 报告一个ABGA病例,在成年人中呈现可逆的基底腺损伤.
- 突出ABGA可能引起神经精神病症状的潜力,包括失眠和焦虑抑郁症.
- 强调早期诊断和治疗ABGA相关脑炎的重要性.
主要方法:
- 一名55岁的女性患者呈现出焦虑抑郁障碍,强迫症行为和难以治愈的失眠的亚急性发作.
- 在FLAIR序列上,脑MRI揭示了基底质中的扩散超强度.
- 开始使用静脉注射免疫球蛋白 (IVIg) 治疗.
主要成果:
- 患者在IVIg治疗后经历了显著的临床改善.
- 失眠和精神症状完全消失了.
- 脑部MRI发现可逆的基底质病变被注意到.
结论:
- 这一案例强调了对ABGAs相关脑炎的及时诊断的重要性,该病可以接受治疗,结果有利.
- 这位成年患者的可逆失眠和精神症状扩大了已知的ABGA临床谱.
- 这些发现支持Lethargica脑炎的免疫病原性,特别是高运动形式,正如本案所建议的那样.
更多相关视频
相关概念视频
CNS Depressants: Barbiturates and Benzodiazepines
258
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
258
REM Sleep Behavior Disorder
182
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
182
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171
Amnesia
123
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
123


